Chakraborty RK, Burns B. Systemic inflammatory response syndrome. In: StatPearls. StatPearls Publishing; 2022. Accessed March 7, 2022. http://www.ncbi.nlm.nih.gov/books/NBK547669/
Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials*. Crit Care Med. 2013;41(9):2209–20. https://doi.org/10.1097/CCM.0b013e31828cf412.
Article CAS PubMed PubMed Central Google Scholar
Scharf C, Liebchen U, Paal M, Irlbeck M, Zoller M, Schroeder I. Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis. Crit Care. 2021;25(1):41. https://doi.org/10.1186/s13054-021-03468-x.
Article PubMed PubMed Central Google Scholar
Köhler T, Schwier E, Praxenthaler J, Kirchner C, Henzler D, Eickmeyer C. Therapeutic modulation of the host defense by hemoadsorption with CytoSorb®—basics, indications and perspectives—a scoping review. Int J Mol Sci. 2021;22(23):12786. https://doi.org/10.3390/ijms222312786.
Article CAS PubMed PubMed Central Google Scholar
McGrath S, Sohn H, Steele R, Benedetti A. Meta-analysis of the difference of medians. Biom J. 2020;62(1):69–98. https://doi.org/10.1002/bimj.201900036.
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805. https://doi.org/10.1177/0962280216669183.
Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C (2017). User Manual for Trial Sequential Analysis (TSA) [Pdf]. 2nd Ed. Copenhagen: Copenhagen Trial Unit, pp. 1–119. Downloadable from Ctu.Dk/Tsa. Accessed on: 05.03.2023 Online.
Poli E. Effect of cytoadsorbant device on post-cardio-pulmonary bypass inflammation in ESICM LIVES 2018: Effect of cytoadsorbant device on post-cardio-pulmonary bypass inflammation in ESICM LIVES 2018. Intensive Care Med Exp. 2018;6(S2):40. https://doi.org/10.1186/s40635-018-0201-6.
László I, Von Seth M, Hillered L, et al. Effects of adsorption of cytokines early in septic shock (the ‘ACESS-trial’)—results of the pilot study in 37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3): Brussels, Belgium. 21–24 March 2017. Crit Care. 2017;21(S1):58. https://doi.org/10.1186/s13054-017-1629-x.
Article PubMed Central Google Scholar
Brouwer WP, Duran S, Ince C. Improved survival beyond 28 days up to 1 year after CytoSorb treatment for refractory septic shock: a propensity-weighted retrospective survival analysis. Blood Purif. 2021;50(4–5):539–45. https://doi.org/10.1159/000512309.
Article CAS PubMed Google Scholar
Woitsch S. Verbesserung der intrakraniellen Sauerstoffversorgung während Operationen im tiefen hypothermen Kreislaufstillstand mit Hämoadsorption. 2018;(Der Hauptstadtkongress der DGAI für Anästhesiologie und Intensivtherapie mit Pfl egesymposium und Rettungsdienstforum).
Schädler D, Porzelius C, Jörres A, et al. A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients. Crit Care. 2013;17(S2):P62. https://doi.org/10.1186/cc12000.
Article PubMed Central Google Scholar
Schittek G. Beeinflussung des intensivstationären Therapieverlaufs durch die Einführung der Absorptionstherapie bei Patienten mit septischen Schock und akuten Nierenversagen. Published online 2018.
Born, F. Systemic Inflammatory Response Syndrome in der Herzchirurgie_Kardiotechnik 02–2014 - English Translation.pdf. Published online February 2014. http://armaghansalamat.com/media/brands/Cytosorbents/Literature/2014_Born%20F%20et%20al.,%20Systemic%20Inflammatory%20Response%20Syndrome%20in%20der%20Herzchirurgie_Kardiotechnik%2002-2014%20-%20English%20Translation.pdf
Gliga S, Orth HM, Lübke N, Timm J, Luedde T, Jensen BEO. Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018. Infection. 2021;49(5):945–51. https://doi.org/10.1007/s15010-021-01618-5.
Article PubMed PubMed Central Google Scholar
Mehta Y, Singh A, Singh A, Gupta A, Bhan A. Modulating the inflammatory response with hemadsorption (CytoSorb) in patients undergoing major aortic surgery. J Cardiothorac Vasc Anesth. 2021;35(2):673–5. https://doi.org/10.1053/j.jvca.2020.06.028.
Lebreton G, Dorgham K, Quentric P, Combes A, Gorochov G, Schmidt M. Longitudinal cytokine profiling in patients with severe COVID-19 on extracorporeal membrane oxygenation and hemoadsorption. Am J Respir Crit Care Med. 2021;203(11):1433–5. https://doi.org/10.1164/rccm.202011-4140LE.
Article CAS PubMed PubMed Central Google Scholar
Lewis TC, Merchan C, Toy B, et al. Impact of CytoSorb hemoadsorption on sedation requirements in patients with severe COVID-19 on venovenous extracorporeal membrane oxygenation. ASAIO J. 2021;67(8):856–61. https://doi.org/10.1097/MAT.0000000000001513.
Article CAS PubMed Google Scholar
Garau I, März A, Sehner S, et al. Hemadsorption during cardiopulmonary bypass reduces interleukin 8 and tumor necrosis factor α serum levels in cardiac surgery: a randomized controlled trial. Minerva Anestesiol. 2019. https://doi.org/10.23736/S0375-9393.18.12898-7.
Bok S. CytoSorb: what is the effect on the circulation? in ESICM LIVES 2017: 30th ESICM Annual Congress September 23–27, 2017. Intensive Care Med Exp. 2017;5(S2):44. https://doi.org/10.1186/s40635-017-0151-4.
Laubach CM. Cytokine and DAMP adsorption in septic acute kidney injury in ESICM LIVES 2018: Paris, France. 20-24 October 2018. Intensive Care Med Exp. 2018;6(S2):40. https://doi.org/10.1186/s40635-018-0201-6.
Bottari G, Lorenzetti G, Severini F, Cappoli A, Cecchetti C, Guzzo I. Role of hemoperfusion with CytoSorb associated with continuous kidney replacement therapy on renal outcome in critically III children with septic shock. Front Pediatr. 2021;9:718049. https://doi.org/10.3389/fped.2021.718049.
Article PubMed PubMed Central Google Scholar
Berlot G, Pintacuda S, Moro E, et al. Effects of tocilizumab versus hemoadsorption combined with tocilizumab in patients with SARS-CoV-2 pneumonia: preliminary results. Int J Artif Organs. 2022;45(1):75–80. https://doi.org/10.1177/0391398821989334.
Article CAS PubMed Google Scholar
Bottari G, Murciano M, Merli P, et al. Hemoperfusion with CytoSorb to manage multiorgan dysfunction in the spectrum of hemophagocytic lymphohistiocytosis syndrome in critically Ill children. Blood Purif. 2022;51(5):417–24. https://doi.org/10.1159/000517471.
Article CAS PubMed Google Scholar
Schittek GA, Zoidl P, Eichinger M, et al. Adsorption therapy in critically ill with septic shock and acute kidney injury: a retrospective and prospective cohort study. Ann Intensive Care. 2020;10(1):154. https://doi.org/10.1186/s13613-020-00772-7.
Article PubMed PubMed Central Google Scholar
Akil A, Ziegeler S, Reichelt J, et al. Combined use of CytoSorb and ECMO in patients with severe pneumogenic sepsis. Thorac Cardiovasc Surg. 2021;69(03):246–51. https://doi.org/10.1055/s-0040-1708479.
Wendel Garcia PD, Hilty MP, Held U, Kleinert EM, Maggiorini M. Cytokine adsorption in severe, refractory septic shock. Intensive Care Med. 2021;47(11):1334–6. https://doi.org/10.1007/s00134-021-06512-0.
Article CAS PubMed PubMed Central Google Scholar
Hawchar F, László I, Öveges N, Trásy D, Ondrik Z, Molnar Z. Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study. J Crit Care. 2019;49:172–8. https://doi.org/10.1016/j.jcrc.2018.11.003.
Article CAS PubMed Google Scholar
Kogelmann K, Hübner T, Schwameis F, Drüner M, Scheller M, Jarczak D. First evaluation of a new dynamic scoring system intended to support prescription of adjuvant CytoSorb hemoadsorption therapy in patients with septic shock. J Clin Med. 2021;10(13):2939. https://doi.org/10.3390/jcm10132939.
Article PubMed PubMed Central Google Scholar
Rugg C, Klose R, Hornung R, et al. Hemoadsorption with CytoSorb in septic shock reduces catecholamine requirements and in-hospital mortality: a single-center retrospective ‘Genetic’ matched analysis. Biomedicines. 2020;8(12):539. https://doi.org/10.3390/biomedicines8120539.
Article CAS PubMed PubMed Central Google Scholar
Brouwer WP, Duran S, Kuijper M, Ince C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317. https://doi.org/10.1186/s13054-019-2588-1.
Article PubMed PubMed Central Google Scholar
Schädler D, Pausch C, Heise D, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. Eller K, ed. PLOS ONE. 2017;12(10):e0187015. https://doi.org/10.1371/journal.pone.0187015
Poli EC, Alberio L, Bauer-Doerries A, et al. Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial. Crit Care. 2019;23(1):108. https://doi.org/10.1186/s13054-019-2399-4.
Article PubMed PubMed Central Google Scholar
Hassan K, Kannmacher J, Wohlmuth P, Budde U, Schmoeckel M, Geidel S. Cytosorb adsorption during emergency cardiac operations in patients at high risk of bleeding. Ann Thorac Surg. 2019;108(1):45–51. https://doi.org/10.1016/j.athoracsur.2018.12.032.
Bernardi MH, Rinoesl H, Dragosits K, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery—a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016;20(1):96. https://doi.org/10.1186/s13054-016-1270-0.
Article PubMed PubMed Central Google Scholar
Taleska Stupica G, Sostaric M, Bozhinovska M, et al. Extracorporeal hemadsorption versus glucocorticoids during cardiopulmonary bypass: a prospective, randomized. Controlled Trial Cardiovasc Ther. 2020;2020:1–15. https://doi.org/10.1155/2020/7834173.
Saller T, Hagl C, Woitsch S, et al. Haemadsorption improves intraoperative haemodynamics and metabolic changes during aortic surgery with hypothermic circulatory arrest. Eur J Cardiothorac Surg. 2019;56(4):731–7. https://doi.org/10.1093/ejcts/ezz074.
Santer D, Miazza J, Koechlin L, et al. Hemoadsorption during cardiopulmonary bypass in patients with endocarditis undergoing valve surgery: a retrospective single-center study. J Clin Med. 2021;10(4):564. https://doi.org/10.3390/jcm10040564.
Article CAS PubMed PubMed Central Google Scholar
Hassan K, Brüning T, Caspary M, et al. Hemoadsorption of rivaroxaban and ticagrelor during acute type A aortic dissection operations. Ann Thorac Cardiovasc Surg. 2022. https://doi.org/10.5761/atcs.oa.21-00154.
留言 (0)